|
EDMONTON, ALBERTA--(Marketwire - Nov. 16, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) announced today that it has mailed to its shareholders the notice of special meeting and management information circular in connection with the special shareholder meeting to approve the amalgamation of Afexa and 1625907 Alberta Ltd. (the "Offeror"), a wholly-owned subsidiary of Valeant Pharmaceuticals International, Inc. ("Valeant"). |
